blinatumomab
amgen
['blinatumomab']
#asco23 #asco2023 for children, adolescents, and young adults with b-all in lr first relapse, there was no statistically significant difference in dfs or os between the blinatumomab and standard chemotherapy arms overall.
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News